Advanced liver disease outcomes after hepatitis C eradication by human immunodeficiency virus infection in PITER cohort

BACKGROUND: Liver disease progression after Hepatitis C Virus (HCV) eradication following direct-acting antiviral (DAA) treatment in the real-life setting according to Human Immunodeficiency Virus (HIV) coinfection was evaluated. METHODS: Patients consecutively enrolled in PITER between April 2014 a...

Descripción completa

Detalles Bibliográficos
Autores principales: Quaranta, Maria Giovanna, Ferrigno, Luigina, Monti, Monica, Filomia, Roberto, Biliotti, Elisa, Iannone, Andrea, Migliorino, Guglielmo, Coco, Barbara, Morisco, Filomena, Vinci, Maria, D’Ambrosio, Roberta, Chemello, Liliana, Massari, Marco, Ieluzzi, Donatella, Russo, Francesco Paolo, Blanc, Pierluigi, Verucchi, Gabriella, Puoti, Massimo, Rumi, Maria Grazia, Barbaro, Francesco, Santantonio, Teresa Antonia, Federico, Alessandro, Chessa, Luchino, Gentile, Ivan, Zuin, Massimo, Parruti, Giustino, Morsica, Giulia, Kondili, Loreta A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer India 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220859/
https://www.ncbi.nlm.nih.gov/pubmed/32279177
http://dx.doi.org/10.1007/s12072-020-10034-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220859/
https://www.ncbi.nlm.nih.gov/pubmed/32279177
http://dx.doi.org/10.1007/s12072-020-10034-0

Ejemplares similares